Co-pathological connected primary neurons in a microfluidic device for Alzheimer studies.

This communication presents a novel experimental model for Alzheimer studies, where connected primary neurons were set into subtend, co-pathological states. Cortical neurons were cultured in two separated cell compartments in a microfluidic device. A neurite network was generated in a main channel through the neurite outgrowth from both cell compartments. A gradient of okadaic acid (OA) is generated over this neurite network by perfusion. OA is a phosphatase inhibitor that induces hyperphosphorylation of Tau proteins, a major hallmark in Alzheimer disease. The local OA treatment resulted in a connected "diseased" and "healthy" cell population. Anti-phosphorylated tau (Ser262) staining confirmed different states of phosphorylated Tau proteins, and synapthophysin staining the connection of "healthy" and "diseased" cells. Here, we present a novel in vitro model that opens the possibility to study cellular and molecular propagation mechanisms in neurodegeneration, in Tauopathies (as e.g., in Alzheimer), as well as simultaneous drug effects on connected healthy and diseased cell populations.

[1]  A. Lees,et al.  Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions , 2004, Acta Neuropathologica.

[2]  Dong Hou Kim,et al.  BACE inhibitor reduces APP-β-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration , 2006, Neurobiology of Disease.

[3]  I. Grundke‐Iqbal,et al.  Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid‐treated SY5Y cells , 2001, FEBS letters.

[4]  C. Arias,et al.  Okadaic Acid Induces Early Changes in Microtubule‐Associated Protein 2 and γ Phosphorylation Prior to Neurodegeneration in Cultured Cortical Neurons , 1993, Journal of neurochemistry.

[5]  D. Small Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression? , 2008, Trends in molecular medicine.

[6]  G. Leuba,et al.  Contribution of neural networks to Alzheimer disease's progression , 2009, Brain Research Bulletin.

[7]  Erin M. Schuman,et al.  Microfluidic Local Perfusion Chambers for the Visualization and Manipulation of Synapses , 2010, Neuron.

[8]  L. Mucke,et al.  A network dysfunction perspective on neurodegenerative diseases , 2006, Nature.

[9]  1 The GloBAl eCoNomiC impACT oF demeNTiA Alzheimer ’ s diseAse internAtionAl World Alzheimer report 2010 the GlobAl economic impAct of dementiA , 2022 .

[10]  Amir Shamloo,et al.  Matrix density mediates polarization and lumen formation of endothelial sprouts in VEGF gradients. , 2010, Lab on a chip.

[11]  S. Love,et al.  Tau hyperphosphorylation affects Smad 2/3 translocation , 2009, Neuroscience.

[12]  Thomas M Pearce,et al.  Microtechnology: meet neurobiology. , 2007, Lab on a chip.

[13]  Noo Li Jeon,et al.  Micro-scale and microfluidic devices for neurobiology , 2010, Current Opinion in Neurobiology.

[14]  Ralph G Nuzzo,et al.  Guiding neuron development with planar surface gradients of substrate cues deposited using microfluidic devices. , 2010, Lab on a chip.

[15]  Xiongwei Zhu,et al.  Involvement of Oxidative Stress in Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.

[16]  Wenming Liu,et al.  Microfluidics: a new cosset for neurobiology. , 2009, Lab on a chip.

[17]  J. Simpkins,et al.  An okadaic acid-induced model of tauopathy and cognitive deficiency , 2010, Brain Research.

[18]  Richard S. J. Frackowiak,et al.  Alzheimer's patients engage an alternative network during a memory task , 2005, Annals of neurology.

[19]  A. Delacourte Tau pathology and neurodegeneration: an obvious but misunderstood link. , 2008, Journal of Alzheimer's disease : JAD.

[20]  N. Shahani,et al.  Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. , 2005, Biochimica et biophysica acta.

[21]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[22]  Heinz-Georg Jahnke,et al.  A novel organotypic tauopathy model on a new microcavity chip for bioelectronic label-free and real time monitoring. , 2010, Biosensors & bioelectronics.

[23]  Eytan Ruppin,et al.  Neuronal-Based Synaptic Compensation: A Computational Study in Alzheimer's Disease , 1996, Neural Computation.

[24]  Michele Giugliano,et al.  Micropatterning neural cell cultures in 3D with a multi-layered scaffold. , 2011, Biomaterials.

[25]  D. Galasko,et al.  Intracellular Aβ is increased by okadaic acid exposure in transfected neuronal and non-neuronal cell lines , 2002, Neurobiology of Aging.